Founded
Website
Recent investment activity
KANDO id: 127463
Company type
Developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function.Funding rounds
N/A
( )
Investor | Profile | Country | |
---|---|---|---|
Venrock Associates | The venture capital arm of the Rockefeller Family. |
Investor | Profile | Country | |
---|---|---|---|
ARCH Venture Partners LP | Venture capital firm providing seed and early stage capital, with a special expertise in co-founding and building technology firms from startup | ||
BayStar Capital | |||
Celera Corp | A healthcare company dedicated at first on sequencing human genome; now focused on therapeutics for cancer and other diseases | ||
Chevron Technology Ventures LLC (CTV) | Corporate venturing subsidiary of ChevronTexaco, focusing on the commercialisation and integration of emerging technologies within Chevron | ||
Comdisco Inc | |||
CW Group Inc | |||
Dow Venture Capital | The corporate venture capital unit of Dow Chemical Co | ||
JPMorgan Chase & Co | |||
Oxford Bioscience Partners III LP | |||
Roche Holding Ltd |
Top investment portfolio themes
nanotechnology (1)
medical devices (1)
Actual initial investment stage
Acquisition (1)
Investment activity status
Active investor
Selected investments
Displaying 1 - 5 of 5Company | Profile | Country | Date | Funding | ||
---|---|---|---|---|---|---|
Avantome | Acquisition Initial investment led the round | |||||
Helixis Inc | Medical equipment company that develops low-cost molecular diagnostic products. | Acquisition USD 105,000,000 (USD 105,000,000) | ||||
Illumina Ventures I | Fund Closing | |||||
Nextbio | Acquisition led the round | |||||
Oxford Nanopore Technologies Ltd | Developing the GridION system, a new generation of technology that uses nanopores - very small holes created in electrically resistant membranes. | Venture Exited |